scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1084752577 |
P356 | DOI | 10.1038/LEU.2017.116 |
P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/leu.2017.116 |
P932 | PMC publication ID | 5729340 |
P698 | PubMed publication ID | 28400619 |
P50 | author | Eric W-F Lam | Q55686122 |
P2093 | author name string | Y Yang | |
Y Wang | |||
Y Zhang | |||
J Xu | |||
X Wang | |||
P Chen | |||
Q Liu | |||
B Zhang | |||
J Feng | |||
J Yan | |||
S Huang | |||
J Lou | |||
D Huang | |||
L Yin | |||
B Jin | |||
Y Hao | |||
D Zou | |||
B Ma | |||
K Yu | |||
Y Lyu | |||
P2860 | cites work | The landscape of long noncoding RNAs in the human transcriptome | Q22122065 |
Activation of p53 by MEG3 non-coding RNA | Q24310760 | ||
Insights from genomic profiling of transcription factors | Q24611607 | ||
Maternally expressed gene 3 (MEG3) noncoding ribonucleic acid: isoform structure, expression, and functions | Q24623420 | ||
Wilms tumor 1 mutations in the pathogenesis of acute myeloid leukemia | Q26744111 | ||
The TET2 interactors and their links to hematological malignancies | Q27002485 | ||
Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study | Q27851436 | ||
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics | Q27851661 | ||
Maternally expressed gene 3, an imprinted noncoding RNA gene, is associated with meningioma pathogenesis and progression | Q28115872 | ||
Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus | Q28236741 | ||
Expression, regulation and roles of miR-26a and MEG3 in tongue squamous cell carcinoma. | Q53078040 | ||
WT1 mutations are secondary events in AML, show varying frequencies and impact on prognosis between genetic subgroups. | Q54331723 | ||
Wilms' tumour 1 mutations are associated with FLT3-ITD and failure of standard induction chemotherapy in patients with normal karyotype AML. | Q54564116 | ||
Wilms' tumor 1 mutation accumulated during therapy in acute myeloid leukemia: biological and clinical implications | Q59194331 | ||
Mutations of the TP53 gene in acute myeloid leukemia are strongly associated with a complex aberrant karyotype | Q81402320 | ||
MEG3 imprinted gene contribution in tumorigenesis | Q83603481 | ||
WT1 recruits TET2 to regulate its target gene expression and suppress leukemia cell proliferation | Q28255707 | ||
MDM2 Associates with Polycomb Repressor Complex 2 and Enhances Stemness-Promoting Chromatin Modifications Independent of p53 | Q28271894 | ||
Gene silencing in cancer in association with promoter hypermethylation | Q29617274 | ||
Methylation-induced repression--belts, braces, and chromatin | Q29617487 | ||
Mutation in TET2 in myeloid cancers | Q29619292 | ||
The IG-DMR and the MEG3-DMR at human chromosome 14q32.2: hierarchical interaction and distinct functional properties as imprinting control centers | Q33619072 | ||
Long noncoding RNAs during normal and malignant hematopoiesis | Q33624959 | ||
Rb-mediated chromatin structure regulation and transcriptional repression | Q34290312 | ||
Whole-genome bisulfite sequencing of multiple individuals reveals complementary roles of promoter and gene body methylation in transcriptional regulation. | Q34304018 | ||
An update on LNCipedia: a database for annotated human lncRNA sequences. | Q34446754 | ||
Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression | Q35010490 | ||
Determination and inference of eukaryotic transcription factor sequence specificity | Q35249717 | ||
HOTAIR is upregulated in acute myeloid leukemia and that indicates a poor prognosis. | Q35919361 | ||
Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells | Q36133137 | ||
Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy | Q36161416 | ||
Tumor suppression by MEG3 lncRNA in a human pituitary tumor derived cell line | Q36161900 | ||
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature. | Q36544646 | ||
Alternative genetic pathways and cooperating genetic abnormalities in the pathogenesis of therapy-related myelodysplasia and acute myeloid leukemia | Q36600942 | ||
Acute myeloid leukaemia | Q36663603 | ||
A tumor suppressor and oncogene: the WT1 story. | Q36760031 | ||
Long non-coding RNAs in hematologic malignancies: road to translational research. | Q37325884 | ||
p53 mutations in cancer | Q38069463 | ||
MDM2 overexpression deregulates the transcriptional control of RB/E2F leading to DNA methyltransferase 3A overexpression in lung cancer | Q39325170 | ||
Overexpression of the long non-coding RNA MEG3 impairs in vitro glioma cell proliferation | Q39414139 | ||
DNA methylation of intronic enhancers directs tissue-specific expression of steroidogenic factor 1/adrenal 4 binding protein (SF-1/Ad4BP). | Q39587931 | ||
An upstream insulator regulates DLK1 imprinting in AML. | Q39749745 | ||
Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour | Q40441171 | ||
Methylation at CpG islands in intron 1 of EGR2 confers enhancer-like activity. | Q40620516 | ||
CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes | Q44457525 | ||
Downregulated long noncoding RNA MEG3 is associated with poor prognosis and promotes cell proliferation in gastric cancer. | Q45903254 | ||
Long noncoding RNAs in hematopoietic malignancies | Q46191604 | ||
Epidermal growth factor-induced rapid retinoblastoma phosphorylation at Ser780 and Ser795 is mediated by ERK1/2 in small intestine epithelial cells | Q46673526 | ||
Evidence from pyrosequencing indicates that natural variation in animal personality is associated with DRD4 DNA methylation | Q47587792 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 12 | |
P304 | page(s) | 2543-2551 | |
P577 | publication date | 2017-04-12 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways. | |
P478 | volume | 31 |
Q60922664 | 2-Bromopalmitate targets retinoic acid receptor alpha and overcomes all-trans retinoic acid resistance of acute promyelocytic leukemia |
Q100407536 | A Nuclear Long Non-Coding RNA LINC00618 Accelerates Ferroptosis in a Manner Dependent upon Apoptosis |
Q94526828 | Aberrant LncRNA Expression in Leukemia |
Q57475229 | Bone marrow infiltrated Lnc-INSR induced suppressive immune microenvironment in pediatric acute lymphoblastic leukemia |
Q92016796 | Competitive endogenous RNA (ceRNA) regulation network of lncRNAs, miRNAs, and mRNAs in Wilms tumour |
Q90152273 | Comprehensive Analysis of lncRNA-Mediated ceRNA Crosstalk and Identification of Prognostic Biomarkers in Wilms' Tumor |
Q55287120 | Epigenetic dysregulation of TET2 in human glioblastoma. |
Q64086187 | Increased methylation upstream of the MEG3 promotor is observed in acute myeloid leukemia patients with better overall survival |
Q92153491 | Investigation of Insulin-Like Growth Factor-1 (IGF-1), P53, and Wilms' Tumor 1 (WT1) Expression Levels in the Colon Polyp Subtypes in Colon Cancer |
Q47107587 | Lnc2Meth: a manually curated database of regulatory relationships between long non-coding RNAs and DNA methylation associated with human disease |
Q93079843 | Long Non-Coding RNA in the Pathogenesis of Cancers |
Q90403271 | Long Non-coding RNAs as Functional and Structural Chromatin Modulators in Acute Myeloid Leukemia |
Q50921357 | Long Noncoding RNA MEG3 Inhibits Cell Proliferation and Metastasis in Chronic Myeloid Leukemia via Targeting miR-184. |
Q59329575 | Long non-coding RNAs in hematological malignancies: translating basic techniques into diagnostic and therapeutic strategies |
Q55315467 | Long non-coding RNAs in ovarian cancer. |
Q90566209 | Long noncoding RNAs and their epigenetic function in hematological diseases |
Q42700665 | Potential applications of MEG3 in cancer diagnosis and prognosis |
Q64117499 | Regulatory Network of Two Tumor-Suppressive Noncoding RNAs Interferes with the Growth and Metastasis of Renal Cell Carcinoma |
Q64284722 | Role of microRNAs, circRNAs and long noncoding RNAs in acute myeloid leukemia |
Q92137481 | The Regulatory Roles of Long Noncoding RNAs in Acute Myeloid Leukemia |
Q61796082 | The long non-coding RNA Meg3 is dispensable for hematopoietic stem cells |
Q97072562 | The role of Long Non-Coding RNAs (lncRNAs) and downstream signaling pathways in Leukemia progression |
Search more.